Client Result
Orrick Advises Sequans Communications in Underwritten Public Offering of American Depositary Shares
May.13.2020

May.13.2020
February.24.2020
May.07.2020
May.21.2020
June.08.2020
Orrick has advised San Francisco-based synthetic biology company Twist Bioscience (NASDAQ: TWST) on its $107.4 million follow-on offering.
June.12.2020
June.04.2020
June.23.2020
November.03.2020
December.23.2020
November.20.2020
October.07.2020